DK1377294T3 - Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination - Google Patents

Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination

Info

Publication number
DK1377294T3
DK1377294T3 DK02724212T DK02724212T DK1377294T3 DK 1377294 T3 DK1377294 T3 DK 1377294T3 DK 02724212 T DK02724212 T DK 02724212T DK 02724212 T DK02724212 T DK 02724212T DK 1377294 T3 DK1377294 T3 DK 1377294T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical combination
disease
treat parkinson
neuroactive agents
treatment
Prior art date
Application number
DK02724212T
Other languages
English (en)
Inventor
Ralph Dawirs
Original Assignee
Ralph Dawirs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ralph Dawirs filed Critical Ralph Dawirs
Application granted granted Critical
Publication of DK1377294T3 publication Critical patent/DK1377294T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK02724212T 2001-03-09 2002-03-08 Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination DK1377294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10111486A DE10111486A1 (de) 2001-03-09 2001-03-09 Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit

Publications (1)

Publication Number Publication Date
DK1377294T3 true DK1377294T3 (da) 2006-07-24

Family

ID=7676934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02724212T DK1377294T3 (da) 2001-03-09 2002-03-08 Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination

Country Status (11)

Country Link
US (1) US20040147613A1 (da)
EP (1) EP1377294B1 (da)
JP (1) JP2004526723A (da)
KR (1) KR20040007464A (da)
AT (1) ATE320810T1 (da)
AU (1) AU2002254935A1 (da)
DE (2) DE10111486A1 (da)
DK (1) DK1377294T3 (da)
ES (1) ES2261663T3 (da)
PT (1) PT1377294E (da)
WO (1) WO2002072094A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877802B2 (en) * 2005-07-28 2014-11-04 Duke Univerity Antiparkinsonian action of phenylisopropylamines
JP5756105B2 (ja) * 2009-07-31 2015-07-29 クレラ インコーポレイティッド パーキンソン病の治療のための組成物および方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77658A1 (de) * 1977-06-30 1979-03-26 Byk Gulden Lomberg Chem Fab Alkylsubstituierte piperidin-n-oxide,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
AU1129295A (en) * 1993-01-06 1996-05-23 Neurogen Corporation Certain tricyclic substituted diazabicyclo{3.2.1} octane derivatives
JPH10502923A (ja) * 1994-07-15 1998-03-17 パーデュー・リサーチ・ファンデーション ジヒドレキシジンおよびその置換類似体の光学活性異性体
EP0942726A2 (en) * 1996-12-24 1999-09-22 Fujisawa Pharmaceutical Co., Ltd. Use of aminopiperazine derivatives
EP1042004A4 (en) * 1997-12-31 2004-08-25 Direct Therapeutics Inc METHOD FOR TISSUE PERFUSION
MXPA02001719A (es) * 1999-08-18 2003-09-25 Childrens Medical Center METODOS, COMPOSICIONES Y EQUIPOS PARA PROMOVER LA RECUPERACION DEL DAnO AL SISTEMA NERVIOSO CENTRAL.

Also Published As

Publication number Publication date
DE50206139D1 (de) 2006-05-11
ES2261663T3 (es) 2006-11-16
DE10111486A1 (de) 2002-10-02
JP2004526723A (ja) 2004-09-02
WO2002072094A2 (de) 2002-09-19
AU2002254935A1 (en) 2002-09-24
EP1377294B1 (de) 2006-03-22
KR20040007464A (ko) 2004-01-24
US20040147613A1 (en) 2004-07-29
PT1377294E (pt) 2006-08-31
EP1377294A2 (de) 2004-01-07
WO2002072094A3 (de) 2003-01-23
ATE320810T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
DK1443955T3 (da) PDGF-BB til behandling af Parkinsons sygdom
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
DK2527315T3 (da) Forbindelser, præparater og fremgangsmåder til behandling af amyloide sygdomme og synukleinopatier, såsom Alzheimers sygdom, type 2-diabetes og Parkinsons sygdom
DK1328269T5 (da) Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme
WO2005053795A3 (en) Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
IS2564B (is) Heterófjölhringjaefnasambönd og notkun þeirra sem metabótrópísk mótlyf gegn glútamat viðtökum
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
MY142214A (en) Prophylactic or therapeutic agent for depression or anxiety disorder
DE60025639D1 (de) Substituierte diazepan
DK1670903T3 (da) Behandling af neurodegenerative sygdomme
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
DE60133385D1 (de) (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
CR9917A (es) Moduladores de cannabinoides hexahidro-cicloheptapirazol
DK1377294T3 (da) Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination
MA26397A1 (fr) Protege-orteils, particulierement pour chaussures de securite.
EA200400438A1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной гипертонии
HRP20040186B1 (en) Use of lhrh-antagonists for the improvement of t-cell mediated immunity
BR0006843A (pt) Dispositivo de embreagem
DE60311284D1 (de) 4-(3,5-dicyanophenoxy)pyrazol-derivate zur verwendung als reverse transkriptase modulatoren zur behandlung von u.a. hiv
TW200505435A (en) Treatment of ocular disorders